In a recent issue of JAMA Network Open, Aaron Kesselheim and colleagues published the results of a study showing that some of the most heavily advertised drugs are essentially no better at treating disease than other options. Almost two dozen complaints submitted to the FCC focused on the number of pharma ads on TV, with consumers arguing that there were “simply too many.”

IN SUMMARY: Proponents of DTC advertising argue that advertisements can raise awareness about treatments and health conditions, though others say that DTC advertising can lead to overprescribing. However, the authors of a recent study found that information seeking behavior following exposure to DTC advertising. Some of these studies associated information seeking more strongly with patients with chronic conditions and those with a more positive view of DTC advertising.